Neurochecklists is undergoing a major transformation.
From a static database it is becoming a live action AI-powered site.
To herald this change, here are 112 recently updated checklists,
All from the latest in the neurology literature.
***
Alzheimer’s disease (AD): clinical features
Alzheimer’s disease (AD): drug treatments
Alzheimer’s disease (AD): investigational treatments
Alzheimer’s disease (AD): protective factors
Autoimmune nodopathy: clinical features
***
Becker muscular dystrophy (BMD): clinical features
Bell’s palsy: clinical features
CANVAS syndrome: clinical features
Cerebral amyloid angiopathy (CAA): classification
Cerebral amyloid angiopathy (CAA): intracranial haemorrhage
Cerebral aneurysms: clinical features
Cerebral vein thrombosis (CVT): investigations
***
Charcot Marie Tooth disease (CMT): classification
Chiari malformation: clinical features
Cluster headache: interventional treatments
Corticobasal syndrome: clinical features
Diabetic neuropathy: treatment
Duchenne muscular dystrophy (DMD): steroid management
Echinococcosis: clinical features
***
Epilepsy and pregnancy: preconception
Essential tremor (ET): pathology
Febrile infection related epilepsy (FIRES) syndrome
Generalized epilepsy with focal evolution (GOFE)
Guillain Barre syndrome (GBS): pathogenesis
Hereditary spastic paraparesis 15 (HSP15)
***
Idiopathic intracranial hypertension (IIH): differentials
Idiopathic intracranial hypertension (IIH): stenting
IIH without papilloedema (IIHWOP)
Inflammatory myopathy: treatment
KLHL11 paraneoplastic encephalitis: clinical features
LGI1 autoimmune encephalitis: clinical features
Limb girdle muscular dystrophy 2I (LGMD2I)
Lyme neuroborreliosis: management
***
MOG antibody disease (MOGAD): differential diagnosis
MOG antibody disease (MOGAD): MRI features
MOG antibody disease (MOGAD): treatment
Motor neurone disease (MND): genetic risk factors
Motor neurone disease (MND): investigational drug treatments
Motor neurone disease (MND): non-genetic risk factors
Multiple sclerosis (MS) and breastfeeding
Multiple sclerosis (MS): CSF analysis
Multiple sclerosis (MS): differential diagnosis
Multiple sclerosis (MS): investigational drugs
***
Multiple sclerosis (MS): investigations
Multiple sclerosis (MS): risk factors
MUSK myasthenia gravis (MG): clinical features
Myasthenia gravis (MG) in pregnancy
Myasthenia gravis (MG): investigational treatments
Myasthenia gravis (MG): unusual phenotypes
Neoplastic meningitis: investigations
Neurofibromatosis type 1 (NF1): surveillance
Neuromyelitis optica spectrum disorder (NMOSD): prognostic factors
***
Neuromyelitis optica spectrum disorder (NMOSD): treatment
Neurosarcoidosis: cranial features
Normal pressure hydrocephalus (NPH): clinical features
Normal pressure hydrocephalus (NPH): treatment
Paraproteinaemia: classifications
Parkinson’s disease (PD): deep brain stimulation (DBS)
***
Parkinson’s disease (PD): differential diagnosis
Parkinson’s disease (PD): risk factors
Persistent postural perceptual dizziness (PPPD)
Prader Willi syndrome: neurological features
Radiologically isolated syndrome (RIS)
Recurrent cervical artery dissection (CAD)
Refractory status epilepticus: treatment
Reversible cerebral vasocinstriction syndrome (RCVS): differential diagnosis
***
Seizures: investigational medications (ASMs)
Self-limiting epilepsy with centrotemporal spikes (SELECTS)
Spinocerebellar ataxia 27A (SCA27A)
Spinocerebellar ataxia 28 (SCA28)
Spinocerebellar ataxia with axonal neuropathy 1 (SCAN1)
Spontaneous intracranial hypotension (SIH): clinical features
Stiff person syndrome (SPS): clinical features
***
Stroke: investigational treatments
Stroke: treatment with atrial fibrillation
Tourette syndrome (TS): drug treatments
Trigeminal neuralgia (TN): treatment
Tropical spastic paraparesis (TSP): clinical features
TTR amyloidosis neuropathy: investigations
Tuberculous (TB) meningitis: complications
***
Vein of Galen aneurysmal malformation (VGAM)
***
WATCH THIS SPACE!!!
The Neurology Lounge 
Leave a comment